Marker Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. 

CEO
Juan F. Vera
CEOJuan F. Vera
Employees
8
Employees8
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
1991
Founded1991
Employees
8
Employees8

MRKR Key Statistics

Market cap
36.95M
Market cap36.95M
Price-Earnings ratio
-2.23
Price-Earnings ratio-2.23
Dividend yield
Dividend yield
Average volume
19.91K
Average volume19.91K
High today
$4.55
High today$4.55
Low today
$4.15
Low today$4.15
Open price
$4.40
Open price$4.40
Volume
19.63K
Volume19.63K
52 Week high
$9.68
52 Week high$9.68
52 Week low
$0.6706
52 Week low$0.6706
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.